A drug delivery system based on fully biodegradable thermosensitive hydrogels enabling controlled antibiotic release may support the management of implant-associated infections. In this work, the lipopeptide antibiotic daptomycin was encapsulated in hydrogel networks consisting of vinyl sulfonated triblock copolymers of PEG-p (HPMAm-lac 1,2 ) and thiolated hyaluronic acid. High concentrations of active daptomycin exceeding the minimum biofilm eradicating concentration were sustainably eluted from the biodegradable carrier. The drug release profiles were tailored by varying the degree of substitution (DS) of thiol groups of hyaluronic acid, reaching a plateau level after 200 and 330 h for DS values of 53% and 31%, respectively. The hydrogel polymeric network preserved the structural stability of the loaded antibiotic and retained the calcium-dependent daptomycin activity, showing a noticeable biofilm bactericidal effect against a 24 h-old Staphylococcus aureus biofilm in vitro. The two-component thermosensitive hydrogels demonstrated to be an excellent antibiotic releasing scaffold with potential clinical applications in the management of implant-associated infections.
Introduction
The steadily rising number of implanted joint arthroplasties and internal fixation devices is paralleled with an increasing number of surgical infections, which represent a significant clinical, socio-economic and public burden [1, 2] . Similarly, implant-associated vertebral osteomyelitis also represents a serious life threatening clinical condition [3] .
The majority of orthopedic infections is due to the microbial colonization of abiotic surfaces, which evolves into biofilm formation. Biofilms are communities of sessile microorganisms surrounded and protected by a self-produced extracellular matrix which shields cells from the host immunity and antimicrobials [4] . Therefore, biofilmembedded cells adhered on implants acquire a greater resistance to antimicrobial killing [5] , as compared to the free-floating microbial cells. The most common pathogens isolated in bone and implant-associated infections are Staphylococcus aureus and coagulase-negative staphylococci, causing more than 50% of periprosthetic [2] , bone fracture fixation-associated and spinal implant-associated infections [6] .
An effective eradication of biofilm infections involving the musculoskeletal system requires surgical revision(s) and prolonged systemic antibiotic treatment [7] . One of the current pharmacological therapies is based on the combination of daptomycin with antibiotics belonging to different classes. Daptomycin is a cyclic lipopeptide antibiotic, which displays a dose-dependent killing activity against a broad range of gram-positive bacteria [8] , acting in a calcium-dependent manner on the bacterial cell membrane [9] . Having demonstrated effective bone and synovial fluid penetration [10] , daptomycin represents one of the therapeutic options for the management of prosthetic joint infections [8, 11] and, in combination with rifampicin, it showed an anti-biofilm activity in an in vivo guinea pig tissue-cage model against staphylococcal biofilm [12] . However, the prolonged systemic antibiotic therapy exposes patients to a number of severe side effects. The combined use of local antimicrobial therapy allows reaching high drug concentrations locally [13] with low systemic toxicity [14] [15] [16] .
One of the biomaterials mainly employed as antibiotic delivery carriers in the management of bone and implant-associated infections is the non-resorbable poly(methyl methacrylate) (PMMA) cement [17, 18] . The non-biodegradability of the aforementioned material carries many disadvantages like the need for surgical removal after drug elution to enable bone grafting, as well as the eventuality of infection recurrence due to the colonization of the unloaded scaffold [19] . Therefore, biodegradability has become an essential feature for materials that find applicability as drug releasing vehicles. Biomaterials expressing good biocompatibility and adequate degradation profile are commonly used in the clinical routine [20] [21] [22] . Biphasic bone graft substitutes deriving from the combination of calcium sulfate and hydroxyapatite have been extensively used in the orthopedic field thanks to their biocompatibility, porous structure and biodegradability [23] . In the continuously evolving panorama of biomaterials for the management of bone and implant-associated infections, cancellous bone [24] , collagen implants [25] , calcium phosphates [26, 27] , allograft bones [28] and bioactive glasses [29] also find a wide applicability. Hydrogels have gained increasing interest as biodegradable vehicles for the local controlled release of antimicrobials thanks to their biofriendly features and full biodegradability [30] . Hydrogels are crosslinked networks of hydrophilic polymers that are able to retain large amounts of water, still maintaining their three-dimensional structure and remaining insoluble. Fundamental features like soft nature and high biocompatibility minimize tissue inflammation and cell adhesion. Hence, hydrogels represent excellent candidates for tissue engineering [31, 32] and for the controlled release of therapeutic agents [33] [34] [35] , preserving peptide/protein structure and function after release in vitro [31, 33] . Among the different types of hydrogels, injectable thermosensitive hydrogels can be delivered in a minimally invasive manner and present tailorable properties, such as mesh size, mechanical resistance, swelling and degradation [36] . In situ-gelling hydrogels have been successfully employed as vehicles for the local delivery of therapeutically active molecules in vitro and in vivo [37] .
In previous studies, a novel thermosensitive injectable hydrogel based on vinyl sulfone bearing p(HPMAm-lac 1,2 )-PEG-p(HPMAm-lac 1,2 ) cross-linked with thiolated hyaluronic acid by thermal gelation and Michael addition was described for potential application as regenerative cell scaffold and drug delivery system [35] . Besides showing excellent in vitro and in vivo biocompatibility and tailorable mechanical and degradation features [35] , the hydrogel system also demonstrated a potential anti-inflammatory effect due to a decreased release of proinflammatory cytokines in hydrogel-treated mice [38] .
Herein, the formulation and characterization of the previously developed thermosensitive hydrogels were further investigated and customized for the controlled release of daptomycin in the management of bone and implant-associated infections. Specific attention was paid to the gel formulation strategy, release and preservation of the drug stability loaded in the biodegradable scaffold. Additionally, in vitro antimicrobial susceptibility tests were performed to assess daptomycin release based on its antibiotic activity and the anti-biofilm efficacy against bacteria mainly responsible for orthopedic implant associated infections.
Materials and methods

Materials
Unless indicated otherwise, chemicals were obtained from Sigma Aldrich (Stenheim, Germany) and were used as received. Research grade sodium hyaluronate produced from microbial fermentation and hydrolyzed to a molecular weight of 33,000 Da was supplied by Lifecore Biomedical, LLC (Chaska, MN, USA). Hydroxyl propyl methacrylamide monolactate (HPMAm-lac 1 ) and dilactate (HPMAm-lac 2 ) were synthesized according to the method described by Neradovic et al. [39] . The synthesis of p(HPMAm-lac 1-2 )-PEG triblock copolymers was carried out according to the procedure reported by Vermonden et al. [40] . 3,3′-Dithiobis(propanoic dihydrazide) (DTP) was synthesized by the method described by Vercruysse et al. [41] . Daptomycin was provided by the manufacturer (Novartis Pharma Schweiz, Basel, Switzerland) and obtained as a powder.
2.2.
1 H NMR spectroscopy NMR spectra were recorded with a Varian Mercury Plus 400 MHz NMR spectrometer (Varian Inc., Palo Alto, CA, USA) and Ascend TM 500 MHz NMR spectrometer (Bruker Corporation, Billerica, MA, USA) using CDCl 3 and DMSO-d 6 as solvents. Chemical shifts were referred to the solvent peak.
Synthesis of vinyl sulfonated triblock copolymer
An ABA triblock copolymer composed of a central PEG chain (Mw 10 kDa) as hydrophilic B-block and thermosensitive side A-blocks of HPMAm-lac 1,2 was synthesized by free-radical polymerization, following the procedure reported by Vermonden et al. [40] . The triblock copolymer was then derivatized with vinyl sulfone moieties to introduce chemically cross-linkable sites, as previously described [35] . The degree of substitution (DS) with vinyl sulfone groups was defined as percentage of the free OH groups that have been modified. Vinyl sulfone bearing copolymers are indicated as VinylSulfTC_n, where n indicates the DS. VinylSulfTC_10 was synthesized by dissolving divinyl sulfone (DVS) (114 mmol) in 100 mL dimethyl sulfoxide (DMSO). Subsequently, 3-mercapto propionic acid (3-MPA) (5.7 mmol) was added dropwise to the previously prepared solution at a molar ratio of 1:20 compared to DVS and the reaction was stirred at room temperature for 4 h. Separately, p(HPMAm-lac 1-2 )-PEG (0.221 mmol, corresponding to 28.5 mmol of free OH groups), 4-(dimethylamino)pyridinium-4-toluensulfonate (DPTS) (0.85 mmol) and N,N′-dicyclohexylcarbodiimide (8.5 mmol) were dissolved in DMSO (10 mL per gram of triblock copolymer) and added dropwise to the previous mixture at a molar ratio of 5:1 between free hydroxyl groups of p(HPMAm-lac 1-2 )-PEG and 3-MPA. The reaction was stirred at room temperature for 24 h. The VinylSulfTC_15 was synthesized by an analogous procedure using a 50% higher amount of DVS and 3-MPA. The product was purified by extensive dialysis (MWCO 12-14 kDa, Medicell International Ltd, London N1 1LX, UK) at 4°C against deionized water and obtained as a white powder after freeze-drying. The DS was determined by 1 H NMR and calculated using the Eq. (1), 
Synthesis of thiolated hyaluronic acid (HASH)
Hyaluronic acid was derivatized with thiol groups by slightly modifying the procedure described by Shu et al. [42] . The extent of thiol derivatization, also called DS, is defined as the number of DTP residues per 100 disaccharide units. As reference procedure, to obtain a DS of 50%, 1.0 g of sodium hyaluronate (Mn 33.0 kDa) was dissolved in 100 mL sterile water and 482 mg of DTP was added while stirring. The pH (determined with pH meter Jenway, Bibby Scientific Ltd, Stone, Staffordshire, OSA, UK) was adjusted to 4.7 with HCl 2 M and, subsequently, 388 mg of 1-ethyl-3-[3-(dimethylamino)propyl]-carbodiimide was added maintaining the pH at 4.75. The solution was stirred at room temperature for 48 h and the reaction was stopped by increasing the pH to 7.0 using 5 M NaOH. Then, dithiothreitol was added as a reducing agent and pH was raised to 8.5. The reaction mixture was stirred for further 24 h at room temperature. Afterwards, the pH was decreased to 3.5 by addition of 1 M HCl to stop the reaction. The product was purified extensively by dialysis (MWCO 3500 Da) against acidified water (pH 3.5) containing 100 mM sodium chloride (NaCl) and finally against water at 4°C. The final product was obtained as a white powder after freeze-drying (Labconco Corporation, Kansas City, MO, USA 
Daptomycin-loaded thermosensitive hydrogel formulation
VinylSulfTC_n was dissolved in daptomycin basic solution (28 mg/ mL, pH 8.0) at 4°C, whereas HASH_n′ was separately dissolved at room temperature in daptomycin acid solution (28 mg/mL, pH 4.5). Upon complete dissolution, thiolated hyaluronic acid was added to the triblock copolymer solution. The final concentration of triblock copolymers was 10% and 15% w/v, whereas the concentration of HASH_n′ was calculated to obtain a 1:1 M ratio between vinyl sulfone and thiol groups. Upon mixing, the final solution of VinylSulfTC_10 and HASH_n′ was placed in a preheated oven at 37°C to allow for thermal gelation and simultaneous Michael Addition cross-linking. The different hydrogel formulations are reported in Table 1 .
Daptomycin-loaded physical hydrogel formulation
Physical hydrogels (Table 1) were formulated dissolving hyaluronic acid sodium salt (Mn 37.9 kDa) in daptomycin solution (28 mg/mL, pH 7.4) at a final concentration of 10% w/v. Upon mixing, the final solution was placed in a preheated oven at 37°C.
Swelling and degradation studies
Thermosensitive daptomycin-loaded hydrogels (10% w/v) were prepared in cylindrical glass vials, as described above. Next, 0.4 mL of phosphate buffer (pH 7.4) was added on top of the gels and the vials were incubated at 37°C. At regular time intervals, swollen hydrogels were weighed (W t ) after buffer removal. Upon each measurement, the buffer was replenished. The swelling ratio (SR) of the gels was calculated from the initial hydrogel weight after formulation (W 0 ) and the swollen hydrogel weight upon buffer removal (W t ) according to the following equation: SR = W t /W 0 .
Daptomycin release studies
Hydrogels with a volume of 100 µL were formulated in vials as described above. Next, 400 µL of PBS (pH 7.4) were applied on top of the hydrogels and the vials were incubated at 37°C under shaking (350 rpm) using an IKA vortex 4 digital (IKA®-Werke GmbH & Co. KG, Janke & Kunkel-Str. 10 79219 Staufen, Germany). At different time points, 300 µL of medium were periodically withdrawn and replaced by an equal volume of fresh buffer. Sink conditions were maintained in the compartment during release studies. All samples were analyzed by High Performance Liquid Chromatography (HPLC), slightly modifying the procedure reported by Muangsiri et al. [45] . Analysis were performed on a HPLC-MS Agilent 1100 Series (Agilent Technologies Inc., Santa Clara, CA, USA) using a Zorbax SB-AQ C18 (Agilent Technologies Inc., Santa Clara, CA, USA) 5 µm, 150 × 4.6 mm column set at the temperature of 30°C, retention time 6 min. Isocratic elution of eluent A (52%; water/formic acid (15 mM)/triethylamine (pH 3.5)), eluent B (30%; acetonitrile) and eluent C (18%; methanol) at a flow rate of 1.0 mL/min was applied to run 5.0 µL volume samples. Detection was performed at the wavelength of 223 and 245 nm. The target mass was 1600 m/z with a positive polarity.
Daptomycin degradation studies
Daptomycin-loaded hydrogels with varying solid polymer content were formulated as reported above and incubated at 37°C in sealed vials. At different time points, aliquots of hydrogel were sampled and mixed with 200 µL of PBS (pH 7.4). The mixture was then centrifuged at 15000 rpm for 30 min at 4°C. Afterwards, the supernatant was analyzed by HPLC-MS, following the method described in Section 2.8. As reference, a daptomycin solution (pH 7.4, concentration of 28 mg/mL) was incubated at 37°C and, at different time points, aliquots of aged daptomycin solution were sampled and analyzed by HPLC-MS. The extent of daptomycin degradation was evaluated considering the relative area under the chromatographic peak of degradation products, as compared to that of the native drug. To further confirm whether the daptomycin degradation occurred, 1 H NMR analysis of the freeze-dried samples was also performed. Daptomycin was dissolved at a concentration of 2.8 mg/mL in PBS buffer (pH 7.4). These conditions reflected those used in the formulation process (Section 2.5) and during the release tests (Section 2.8). The prepared daptomycin solution was stored at 37°C for 20 days and at different timepoints stability tests of the lyophilized drug were run by 1 H NMR. A laboratory strain of methicillin-resistant S. aureus (MRSA ATCC 43300) was used in this study. The bacterial strain was stored in cryovial bead preservation system (Microbank; PRO-LAB DIAGNOST-ICS, Richmond Hill, ON, Canada) at −80°C and cultured on Trypticase Soya agar (TSA) plates (Becton, Dickinson and Company, Heidelberg, Germany) for 24 h at 37°C.
Daptomycin was obtained as a powder and dissolved in sterile pyrogen-free 0.9% saline. For hydrogel formulation, two different solutions of daptomycin were prepared at a concentration of 28 mg/mL dissolving the powder in acid phosphate buffer (pH 4.5, 0.1 M) and basic phosphate buffer (pH 8.0, 0.1 M), respectively.
Daptomycin antibacterial and anti-biofilm activity by broth macrodilution and sonication/colony counting
The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of daptomycin against planktonic S. aureus were determined by broth macrodilution method following the CLSI guidelines [47] . Briefly, 1-5 × 10 5 Colony Forming Units (CFUs)/ Table 1 Polymer composition of the different formulated hydrogels. A 1:1 ratio between vinyl sulfone and thiol groups was used for all formulations. Trypticase Soya broth (TSB) for 24 h at 37°C. The ratio between glass beads and bacterial suspension was 1 bead: 1 mL. After incubation, beads were rinsed three times with 0.9% sterile saline and exposed to two-fold serial dilutions of daptomycin in CAMHB for 24 h. A positive control consisting of biofilm incubated without treatment was included, as well as a sterile bead as negative control. After washing, beads were transferred to 2 mL-Eppendorf containing 1 mL PBS buffer (pH 7.4, 10 mM), vortexed for 30 s, sonicated at 40 kHz for 1 min in a bath sonication instrument at 40 kHz and 0.2 W/cm 2 (BactoSonic, Bandelinelectronic, Berlin, Germany) and finally vortexed for 30 s, as previously described [48, 49] . The dislodged biofilm (sonication fluid) was serially diluted and aliquots thereof were plated on TSA plates (92 mm diameter) and aerobically incubated at 37°C for 24 h (plating detection limit 20 CFUs/mL). Bacterial colonies were counted and expressed as CFUs/mL. The minimum biofilm eradicating concentration (MBEC) was defined as the lowest antibiotic concentration required to eradicate the biofilm (0 CFUs/bead on plate counts). For both planktonic and biofilm tests, CAMHB was supplemented with 50 mg/L CaCl 2 for daptomycin activity.
Daptomycin-loaded thermosensitive hydrogel formulation
Daptomycin-loaded hydrogels of a volume of 400 µL were prepared in cylindrically shaped ampoules (6 mm diameter) as follows. Vinyl sulfonated triblock copolymer (VinylSulfTC_10) was solubilized in daptomycin solution (28 mg/mL, pH 8.0) at a final concentration of 15% w/v at 4°C. Thiolated hyaluronic acid at different degrees of thiolation (HASH_n′; DS 31 and 53%) was dissolved in daptomycin solution (28 mg/mL, pH 4.5) and added to the VinylSulfTC_10 solution.
The molar ratio between vinyl sulfone groups and thiol groups was 1:1. Upon mixing, the ampoules containing the final solution of VinylSulfTC_10 and HASH_n′ were air-tight sealed and placed in a ambient air incubator at 37°C to allow thermal gelation and simultaneous Michael Addition cross-linking between thiol and vinyl sulfone groups. As determined by the tilting vial method [50] , the sample showing no flow was considered a gel.
2.10.4. Drug release from thermosensitive daptomycin-loaded hydrogels, agar well diffusion assay and calculation of active daptomycin concentration Daptomycin-loaded hydrogels were prepared as described above and incubated at 37°C until the sample showed no flow behavior. Next, 1.6 mL of PBS buffer (pH 7.4, 10 mM) supplemented with 50 mg/L CaCl 2 were added on top of the hydrogels and the ampoules were incubated under static conditions at 37°C. At any time point, the buffer was removed and replaced by an equal amount. The concentration of active daptomycin in the buffer was determined by using the agar well diffusion assay against MRSA, as previously reported [51] . Briefly, a bacterial inoculum was prepared according to a McFarland standard turbidity of 0.5 (≈10 8 CFUs/mL, λ = 565 ± 15 nm) and a sterile cotton swab was dipped into the bacterial suspension. The entire surface of Müller Hinton agar (MHA) plates was carefully streaked evenly in three directions and the excess of moisture was allowed to be fully absorbed. A 6 mm hole was punched on inoculated plates and filled with 60 µL of sampled buffer. After 24 h incubation at 37°C, inhibition halos were measured and the concentration of active daptomycin was calculated using the equation reported in Fig. S1 . Supplementary data associated with this article can be found, in the online version, at https://doi.org/10.1016/j.ejpb.2018.07.001.
The same experimental procedure was adopted to evaluate also the retention of antibiotic activity of a free daptomycin solution (pH 7.4, 28 mg/mL) over a prolonged incubation at 37°C. At different time points, from 0 to 21 days, 60 µL of aged solution were sampled and dropped in the punched hole, without refilling the corresponding volume of fresh buffer. The inhibition halos were measured after 24 h incubation.
Anti-biofilm activity of daptomycin-loaded hydrogels by isothermal microcalorimetry
The microcalorimetric analysis was performed using a 48-channel isothermal microcalorimeter (TAM III; TA Instruments, New Castle, DE, USA), as previously described [49, 52] . Briefly, MRSA ∼1 × 10 7 CFUs/ Fig. 1 . Chemical structure of daptomycin with ionizable amino acid residues circled in red (A). Comparison between 1 H NMR spectra of daptomycin freshly dissolved in phosphate buffer at pH 7.4 and 37°C (B) and daptomycin dissolved in phosphate buffer at pH 7.4 and 37°C aged for twenty days (C).
mL were inoculated in TSB and incubated with porous glass beads (VitraPor; ROBU, Germany) (diameter 2-3 mm, pore size 60 µm) for 24 h at 37°C. A ratio of 1 bead: 1 mL was considered between glass beads and bacterial suspension. Then, glass beads were gently rinsed three times with 0.9% sterile saline and co-incubated with a 400 µL-daptomycin-loaded hydrogel (VinylSulfTC_10/HASH_53) in air-tight sealed microcalorimetric ampoules filled with CAMHB. A positive control consisting of untreated biofilm was included, as well as a sterile bead as negative control. After 24 h co-incubation and monitoring in the microcalorimeter, beads were washed and placed in sealed ampoules containing 3 mL of fresh medium to monitor for 48 h the heat produced by biofilm cells still viable after the treatment. Results were plotted as heat flow (µW, microwatts) versus time and as total heat (J, joules) versus time.
Results and discussion
Daptomycin stability studies
As many protein drugs, daptomycin degrades under physiological conditions [45] . The loss of structural and functional stability of the drug poses important limitations in its potency and efficacy in vivo and in the possibility to formulate sustained delivery systems aimed at releasing active drug over a prolonged period of time upon administration. Therefore, the investigation of new formulation strategies for the simultaneous stabilization and controlled release of the drug is of paramount importance. The first part of the present study is devoted to the formulation of thermally and chemically cross-linked hydrogels displaying a dual function of drug stabilizer and local sustained delivery system. Different hydrogels were formulated by mixing the two hydrogel precursors, thiolated hyaluronic acid and vinyl sulfone triblock copolymer (VinylSulfTC_n), in PBS buffer at pH 7.4 and room temperature in the presence of daptomycin at the concentration of 28 mg/ mL. Different hydrogel formulations were prepared by varying the DS% of vinyl sulfone groups (10% and 15% for VinylSulfTC_10 and VinylSulfTC_15, respectively), the DS of thiol groups (31% and 53%, for HASH_31 and HASH_53 respectively) and the final concentration of VinylSulfTC_n (15% and 20% w/v). When the solutions of drug and hydrogels polymeric precursors were incubated at 37°C, thermal gelation and tandem Michael addition cross-linking occurred in time [35] . All hydrogels were fully cross-linked after approximately 13-14 h of incubation.
To test the ability of the hydrogel network to prevent premature daptomycin degradation, the structural stability of the drug was investigated by 1 H NMR (Fig. 1) and HPLC (Fig. 2) by comparing, at different time-points, the drug released from the different hydrogel formulations and the control drug, freshly dissolved in PBS (pH 7.4) at 37°C. The comparison between 1 H NMR spectra of freshly dissolved daptomycin in phosphate buffer at pH 7.4 and 37°C and daptomycin solution in phosphate buffer at pH 7.4 aged for twenty days at 37°C is represented in Fig. 1 and shows that, after 20 days of incubation of the drug at physiological conditions, the peaks assigned to the protons of the aromatic rings of Trp-1 and Kyn-13 (Fig. 1A ) at 6.6-7.4 ppm, as well as the peak referring to the proton of Thr-4 (Fig. 1A) at 5.5 ppm, disappeared. (Fig. 1C) . Only the peaks appearing at ppm values lower than the solvent peak were detected after 20 days and referred to the methane, methylene and methyl groups present in the molecule These results clearly indicated a chemical change in the structure of the ionizable amino acid residues of the native drug, which is most likely associated to the loss of antibiotic activity, as later reported.
The tendency of the drug to undergo structural degradation due to the opening of the 10-terms ring and the formation of ring opening products was further investigated by HPLC-MS, allowing for a qualitative and quantitative analysis of native daptomycin and degradation products thereof. The different physico-chemical characteristics of daptomycin and its degradation products ( Fig. 2A) permitted a clear detection of the analytes at different retention times. Online MS analysis enabled the identification of peak 1 in Fig. 2B as native daptomycin, peak 2 as ring-opened product and peak 3 as anhydrous daptomycin. In line with 1 H NMR results, the relative abundance of daptomycin degradation products increased in time, with a consequent continuous decrease of native drug (Fig. 2B) . When daptomycin was loaded within thermosensitive hydrogels hybridized with hyaluronic acid, a higher retention of structure stability compared to the drug stored in pure phosphate buffer was observed. As reported in Fig. 2C , the area under the chromatographic peak of native daptomycin was always higher than the one of degradation products (Fig. 2B) , suggesting that the hydrogel displayed the capacity to stabilize the drug native structure.
As reported in Fig. 3A , in pure buffer solution, daptomycin 
hydrogels (HF) (E). Comparative overview of daptomycin stability loaded in the different tested formulations (F). Daptomycin stability (%) is plotted versus time (h).
continuously degraded in time until reaching a concentration of native drug of only 33% after 20 days and, accordingly, the two degradation products increased in time reaching both a relative abundance of 33% after the same incubation time. When investigating the stability of daptomycin into VinylSulfTC_15/HASH_31 hydrogels (Fig. 3B) , the relative abundance of the native drug reached a value of 57% in a time span of approximately 20 days, anhydrous daptomycin a value 40% and, surprisingly, the ring-opened product was almost completely inhibited as it did not exceed a value of 3%. Taken together, it may be therefore deduced that this specific formulation preserved daptomycin native structure, providing the lipopeptide antibiotic with greater stability as compared to pure PBS by inhibiting the formation of the ringopened product. These encouraging results prompted us to further study the daptomycin-loaded hydrogel systems as controlled releasing vehicles, investigating whether different DS and varying polymer solid content of both components could play a key role in the modulation of drug stability. The analysis of VinylSulfTC_10/HASH_31 (Fig. 3C) and VinylSulfTC_10/HASH_53 (Fig. 3D) highlighted differences in daptomycin decay pathway, as compared to VinylSulfTC_15/HASH_31. Indeed, the chemical stability of daptomycin increased compared to free daptomycin in PBS but, at the same time, the percentage remained at values lower than those observed for VinylSulfTC_15/HASH_31. Specifically, daptomycin loaded in VinylSulfTC_10/HASH_31 reached 45% stability (Fig. 3C ) and a 44% when entrapped in VinylSulfTC_10/HASH_53 (Fig. 3D) . Furthermore, the percentage of ring-opened product increased up to 20% in case of both formulations. To gain deeper insights into the influence of hydrogel network on the drug stability, a physical hydrogel simply composed of hyaluronic acid was formulated dissolving the polymer with a concentrated solution of daptomycin (Fig. 3E) . In this case, for the first 100 h of incubation, daptomycin stability was preserved similarly to what observed for the cross-linked hydrogels. However, a drop in drug stability was detected in the following hours, reaching a final percentage of 34%.
Lastly, a comparison of native daptomycin stability values, when the lipopeptide drug was loaded into either chemical or physical hydrogels, is reported (Fig. 3F) . It can be therefore concluded that chemical thermosensitive hydrogels efficiently improved drug stability over time by limiting the formation of degradation products, with the best formulation being the one composed of VinylSulfTC_15/HASH_31, containing the highest content in thermosensitive polymer and hyaluronic acid of all the formulations tested. Interestingly, the correlation between the solid polymer content and the drug stability is noteworthy. Indeed, the reported data suggested that hydrogels with increasing polymer content, thus displaying higher cross-link density and lower network mesh size, offered the most favorable environment to the drug chemical stabilization. It may be therefore argued that the hydrogel solid polymer content, the elastic modulus of the jellified biomaterial, as well as its resistance to the hydrolytic degradation, directly correlate the structural and chemical stability of the analyzed antibiotic [33, 53] . This conclusion is further confirmed by the observation that physical hydrogels only composed of hyaluronic acid did not demonstrate any remarkable effect in preserving drug stability, most likely because of their poor mechanical properties given by the lack of chemical crosslinks.
In vitro analysis of native daptomycin degradation (Fig. 4) , which was carried out using the agar well diffusion assay against MRSA, showed results in agreement with those previously described. For the standard solution of free drug, indeed, a first drop in antimicrobial activity was observed after ∼100 h of incubation with a 35% reduction (from a concentration of 2.6 to 1.7 mg/mL of active drug). The activity was then unvaried for approximately 15 days. At day 20, a second activity decay was detected, with a decrease in active concentration to ∼1.1 mg/mL. Taken together, in a time span of 3 weeks, an overall 58% reduction in daptomycin antimicrobial activity against MRSA was observed. These data showed good correlation to what observed by HPLC-MS analysis, suggesting that the formation of daptomycin degradation products might be crucial for the reduction of the antimicrobial activity during incubation in PBS.
Swelling and degradation studies
The tested hydrogel formulations demonstrated diverse degradation profiles. Swelling and degradation analysis showed, indeed, a nearly complete degradation of the thermosensitive hydrogel displaying a lower HASH polymer content (3% w/v, HASH_53) after approximately 350 h of incubation at physiological conditions at 37°C, with a maximum SR value of approximately 1.6 in around 48 h. Conversely, hydrogels composed of HASH_31 showed a water uptake up to 2-folds its initial gel weight within 48 h, maintaining a certain structure stability for at least 400 h (Fig. 5 ). These observations are in agreement with those reported by Censi et al. [33] , who described a similar swelling behavior for photopolymerized thermosensitive protein-loaded hydrogels displaying 20% and 35% w/w polymer content. The presence of chemical cross-linking holding the polymer chains from dissolution is responsible for the prolonged stability of the hydrogels when exposed to physiological medium. During incubation in PBS buffer (pH 7.4), the hydrogel structure absorbs water, inducing swelling stresses with the Fig. 4 . Degradation of free daptomycin (pH 7.4, 28 mg/mL) expressed as reduction of antibiotic activity against methicillin-resistant S. aureus (MRSA ATCC 43300) by agar well diffusion assay. Active daptomycin concentration (µg/mL) is plotted versus time (h), (mean ± SD, n = 3). Fig. 5 . Degradation profile of daptomycin from two different formulations of the double-component thermosensitive hydrogels containing a fixed amount of 10% vinyl sulfonated triblock copolymer (15% w/v) and a varying amount of thiolated hyaluronic acid (3% and 5% w/v of HASH_53 ( ) and 31 (◆), respectively) in PBS (pH 7.4) at 37°C. Hydrogel degradation is expressed as swelling ratio (SR), calculated as ratio between the weight of the swollen hydrogels upon buffer removal (W t ) and the initial gel weight (W 0 ); (mean ± SD, n = 3). polymeric network. Hence, the stability of the gel is ensured by the presence of chemical interactions, which keep thermosensitive chains together within hydrophobic domains and can therefore withstand the aforementioned swelling stresses. As soon as hydrophobic cohesion forces are overwhelmed by swelling forces, polymer dissociation occurs causing dissolution of the polymeric chains in the incubation buffer [40] . As previously described [54] , this phenomenon is related to the cleavage of lactate side groups, leading to network higher hydrophilicity and resulting in increased swelling ratio in the first incubation time span. Ultimately, the hydrolysis of thermosensitive blocks connected to the polymer backbone causes hydrogel degradation. In the swelling/degradation studies, the tested hydrogels were formulated maintaining a fixed number of chemical cross-linking between vinyl sulfone and thiol groups and, therefore, a varying initial solid polymer content of HASH. We observed shorter degradation times for hydrogels composed of HASH with higher thiolation degree, whereas gels formulated with HASH_31 displayed a more pronounced resistance to hydrolytic degradation (Fig. 5) .
Hence, in contrast to what previously reported by our group [35] , in which unloaded thermosensitive hydrogels composed of higher polysaccharide content displayed faster degradation profiles, we hypothesized that hydrogels composed of HASH of lower DS, when hosting releasable molecules, may undergo changes in their swelling capacity and water uptake, resulting in less pronounced but longer-lasting degradation rates. Moreover, the presence of higher polysaccharide content could understandably bolster our hypothesis, as it increases polymer chain entanglements, retention of the loaded molecule and, therefore, hydrogel resistance to degradation [32] .
Daptomycin release studies
Daptomycin was easily loaded within thermosensitive hydrogels by mixing daptomycin-saturated polymer solutions at different pH (28 mg/ mL, pH 4.5 and 8.0) just before incubation at 37°C to allow for thermal gelation. The use of an acidic daptomycin solution resulted essential for the successful cross-linking between the triblock copolymer and the thiolated polysaccharide. Indeed, under physiological conditions, daptomycin is positively charged (eNH 3 + ), whereas the non-derivatized hyaluronic acid units express a negative charge (eCOO − ), thus ionic interactions occur. Hence, the use of daptomycin/HASH acid solution, eventually buffered by the daptomycin/VinylSulfTC basic solution, prevented the undesired premature gel formation between HASH and daptomycin, which would lastly prevent hydrogel formulation. The impact of hydrogel composition on daptomycin controlled release was investigated. A continuous release of daptomycin for both formulations containing 3% and 5% w/v HASH was observed up to 300 h. In line with what observed during hydrogels swelling and degradation studies, VinylSulfTC_10/HASH_53 hydrogel displayed higher drug release, reaching a 50% cumulative release, whereas for the formulation composed of HASH_31 a 40% cumulative release was obtained (Fig. 6) . Therefore, in agreement to what observed when investigating daptomycin stability, data suggest that gels displaying higher cross-link density and lower network mesh size offer a more restrictive environment to drug diffusion and a better resistance to hydrolytic degradation, leading to lower release rates [33, 53] .
These particular polymeric compositions favor a bimodal release profile, where the ∼40% and 50% of daptomycin were released within the first 50 h from the gel containing HASH_31 and 53, respectively following a diffusional release mechanism. A second release phase following a zero order kinetic was observed for both formulations, showing a constant daptomycin release during the subsequent 300 h (Fig. 5) . However, the release profiles, as well as the lack of quantitative drug release, were affected by the drug degradation that, especially for the longer time points, tended to level off the release curves of native daptomycin, as the related degradation products increased in relative abundance.
In vitro release-based antibacterial activity of daptomycin
Daptomycin, a cyclic lipopeptide, displays a concentration-dependent bactericidal activity against a variety of Gram-positive bacteria [8] in a calcium-dependent manner on the bacterial cell membrane [9] . Previous studies showed its strong bactericidal activity and good bone penetration [10] . In vivo studies demonstrated that the combined administration of daptomycin and rifampicin exerts an activity against S. aureus biofilms in rabbits [55] and guinea pigs [12] . Therefore, the use of a biodegradable system based on thermosensitive hydrogels for the local controlled release of daptomycin at the infection site might efficiently improve clinical outcomes, as it allows achieving high antibiotic concentrations locally without carrying severe side effects. Preliminary analysis were performed using the conventional broth macrodilution assay to evaluate the antibiotic activity of standard free daptomycin against planktonic and biofilm MRSA. The MIC was 0.5 µg/mL, whereas a bactericidal activity against free-floating MRSA cells was observed with a two-fold higher daptomycin concentration. Indeed, no colonies were detected on agar plates after treatment with 1 µg/mL of antibiotic. The analysis of daptomycin activity against a 24 h-old staphylococcal biofilm revealed that a MBEC (32 µg/mL) 64-times higher than the MIC was needed to completely eradicate sessile bacteria. However, lower daptomycin concentrations (8-16 µg/mL) already exhibited a bactericidal activity with a minimum reduction of 2-log 10 of MRSA adherent cells, as compared to the untreated biofilm (Fig. 7) .
The elution of active daptomycin from the two different hydrogel formulations was monitored over 24 h using the agar diffusion assay, a well-established method which estimates the inhibiting efficacy of the tested antibiotic based on the assumption that drugs can freely diffuse in the solid medium [51, 56] . The two different formulations of the double-component injectable hydrogel, both containing a fixed amount of 10% vinyl sulfonated triblock copolymer (15% w/v) and a varying amount of thiolated hyaluronic acid (3% and 5% w/v of HASH_53 and 31, respectively), showed diverse drug release profiles, in agreement with data obtained by HPLC-MS analysis. Indeed, VinylSulfTC_10/ HASH_53 released a maximum daptomycin concentration of ∼ 1.3 mg/ mL after 24 h incubation, whereas lower concentrations (∼600 µg/mL) were eluted from the gel with higher polymer content after the same incubation time (Fig. 8A) . This evidence suggests that the gel with 5% w/v solid polymer content releases lower amounts of drug but in a longer time span, whereas the counterpart formulated with a lower polymer content (3% w/v) releases higher daptomycin amounts but within a shorter time. This differential behavior is likely due to the varied amount in HASH solid content composing the gel, as described above. Indeed, as compared to gel of 3% w/v polymer content, the formulation containing hyaluronic acid with a lower DS (HASH_31) has a higher polymer content (5% w/v), which therefore increases polymer chain entanglements and hydrogel resistance to hydrolytic degradation, also resulting in a lesser but more prolonged release. Nevertheless, both hydrogels allowed for a sustained release of high daptomycin concentrations not only widely exceeding the MIC and MBC, but also largely outreaching the MBEC against MRSA (Fig. 8A ). These data suggest that an antibiotic preventing activity against early acute infections of surrounding soft tissues and implants could be guaranteed for at least 15 and 8 days after hydrogel injection, when gels are formulated with a higher and lower polymer solid content, respectively. Differently, in the event of establishment of a biofilm infection, anti-biofilm effect could be ensured up to 10 days, when applying VinylSulfTC_10/HASH_31 hydrogel, or 7 days, when administering the faster degrading formulation. Taken together, a cumulative daptomycin release of approximately 40% and 60% of the initial amount of loaded drug was obtained from gels of 5% and 3% w/v of polymer content, respectively (Fig. 8B) . It is noteworthy to also highlight that, differently from other biomaterials characterized by a rapid diffusion-driven bolus release (e.g. collagen-or fibrin-based gels [57] ), the tested hydrogels showed an initial burst release followed by a sustained drug elution up to polymer degradation, in the case of gels of 3% w/v polymer content. This characteristic may represent an improvement in the management of bone and implant-associated infections, as it might prevent bacterial colonization of the bioscaffold after total drug elution.
The in vitro anti-biofilm activity of daptomycin released from the faster degrading gel was evaluated using the isothermal microcalorimetry. When employed as analytical tool for microbiological studies, this non-destructive technique allows for real-time highly sensitive measurements of heat fluctuations due to the metabolic activity of the tested strain, showing a good correlation with standardized conventional antimicrobial susceptibility methods [49, 51, 52] . As showed in Fig. 9A , the growth of biofilm-embedded cells was completely inhibited during the treatment with the daptomycin-loaded gel, as demonstrated by the lack of any heat production, as compared to the biofilm growth control (∼7 × 10 6 CFUs/mL by sonication/colony counting). However, the complete eradication of the mature biofilm was not achieved. Indeed, residual biofilm cells, which survived the antibiotic treatment, led to a regrowth-related heat production when reincubated in fresh medium (Fig. 9B ) after antibiotic removal. Although the shape similarity of the heat flow curves belonging to the treated and untreated biofilms is undeniable, confirming the presence of MRSA on the beads, a significant reduction in the instantaneous heat produced (µW), as well as a temporal shift thereof, is evident after the anti-biofilm treatment. The high concentrations of active daptomycin released from the hydrogel determined a reduction of the higher heat flow peak of more than 100 µW and a delay of about 7.5 h. Overall, a 36% reduction of the total heat produced by the treated biofilm was estimated during the 48 h-incubation. A limitation in our experimental setting was represented by a technical inconvenience faced during the co-incubation of glass bead and thermosensitive hydrogel; namely, the glass bead sank into the gel network, hence possibly preventing the biofilm from being exposed to the high concentrations of active daptomycin released in the supernatant buffer (PBS pH 7.4, 50 mg/L CaCl 2 ). Therefore, further in vivo analysis are required to investigate the real impact of local high concentrations of daptomycin on biofilm-associated infections when the antibiotic is delivered in a controlled manner.
During the incubation of thermosensitive gels with bacteria, we could appreciate a significant degradation of the cross-linked network, which eventually caused the complete disaggregation of the hydrogel within 48 h. Indeed, a cloudy appearance of the degraded gel was observed, probably due to an accelerated enzymatic degradation of hyaluronic acid. Conversely, incubation of hydrogels under sterile conditions guaranteed the structure stability for at least 8 days. These observations led us to speculate on the presence of degrading enzymes (i.e. hyaluronidase) secreted by S. aureus and on their role in chemical bond cleavage of hyaluronic acid units, as also reported for an agarose/ hyaluronan matrix used as bacteriophages delivery system [58] . Bacterial hyaluronidase cleavages hyaluronic acid by β elimination of the Fig. 7 . Antibiotic activity of free daptomycin against a 24 h-old MRSA biofilm. The Colony Forming Units per milliliter (CFUs/mL) are plotted against different concentrations of daptomycin (µg/mL) ranging from 0 (GC) to 128 µg/mL. Cirled value corresponds to the minimum biofilm eradicating concentration (MBEC); GC, growth control; (mean ± SD, n = 3). Fig. 8 . Released active daptomycin (A) and cumulative release (B) from hydrogels containing 10% vinyl sulfonated triblock copolymer (15% w/v) and a varying amount of thiolated hyaluronic acid (3 and 5% w/v of HASH_53 ( ) and 31 (◆), respectively) assayed by agar well diffusion assay. Active daptomycin concentration (µg/mL) is plotted versus time (days), whereas the cumulative daptomycin release is expressed as percentage (%) over time (days). MBEC, minimum biofilm eradication concentration; MBC, minimum bactericidal concentration; MIC, minimum inhibiting concentration; (mean ± SD, n = 3). β-1,4 glycosidic bond and several in vitro and in vivo data [59, 60] strongly suggested its involvement in bacterial virulence as spreading factor and carbon source promoter. Previous in vivo experiments performed in mice aimed to investigate the biocompatibility of the twocomponent thermosensitive hydrogels as degradable scaffolds for drug delivery and tissue engineering. This work demonstrated faster hydrogel degradation rates when the material was injected subcutaneously and intramuscularly, as compared to what observed during in vitro analysis for the same formulations [38] . This shorter residence time in vivo was attributed not only to chemical hydrolytic phenomena, but also to enzymatic degradation (i.e. hyaluronidases of the host) and cellular metabolism. Hence, our observations suggest the involvement of bacterial-secreted degrading enzymes in the biodegradation process of hyaluronic acid-based biomaterials, which could be used as specific trigger for on-demand local controlled release of high concentrations of antibiotics.
Conclusions
In this study, we proposed for the first time the use of thermosensitive hyaluronic acid/p(HPMAm-lac)-based hydrogels as releasing vehicles for the local controlled release of daptomycin in the management of implant-associated infections. Hydrogels were easily formulated via a dual-cross-linking method relying on thermal gelation and Michael Addition, and daptomycin was physically entrapped in the hydrogel during 3D network formation. More importantly, to the best of the authors' knowledge, it was demonstrated for the first time that thermosensitive hydrogels significantly decrease the natural tendency of daptomycin to undergo chemical degradation when simply dissolved in physiological media. The stability of the drug and its release kinetics could be easily tailored to a certain extent by varying the polymeric composition of the gels. A sustained release of antibiotic to clinically relevant concentrations was observed for at least 15 days, following a biphasic release mode. Released active daptomycin concentrations were widely exceeding the minimum inhibiting and minimum bactericidal concentrations against MRSA throughout the whole incubation time. Furthermore, a biofilm bactericidal activity was observed against a 24 h-old S. aureus biofilm in vitro. Taken together, the two-component thermosensitive hydrogels demonstrated to be excellent candidates as minimally invasive delivery system for the local controlled release of daptomycin in the management of implant-associated infections, offering an effective therapeutic option for the prevention and treatment of orthopedic biofilm-associated infections. Fig. 9 . Microcalorimetric analysis of MRSA (ATCC 43300) biofilm during (A) and after (B) 24 h-treatment with thermosensitive daptomycin loaded hydrogels (VinylSulfTC_10/HASH_53). Heat flow (µW) expresses the instantaneous heat produced from the bacterial metabolic activity in real time; it was monitored for 24 h during treatment and for 48 h after treatment. Total heat (J) curves represent the mathematical integration (area under the curve) of heat flow curve and therefore the cumulative heat produced throughout the experiment. Curves represent the heat produced by the untreated biofilm (GC biofilm), the biofilm during treatment with hydrogel (biofilm + VinylSulfTC_10/HASH_53) and the biofilm after 24 h-treatment (treated biofilm). NC, negative control.
